|
1
|
Tao P, Sun L, Sun Y, Wang Y, Yang Y, Yang
B and Li F: ISG15 is associated with cervical cancer development.
Oncol Rep. 24:3802022.
|
|
2
|
Melan K, Janky E, Macni J, Ulric-Gervaise
S, Dorival MJ, Veronique-Baudin J and Joachim C: Epidemiology and
survival of cervical cancer in the French West-Indies: Data from
the martinique cancer registry (2002–2011). Glob Health Action.
10:13373412017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Castro-Muñoz LJ, Manzo-Merino J,
Muñoz-Bello JO, Olmedo-Nieva L, Cedro-Tanda A, Alfaro-Ruiz LA,
Hidalgo-Miranda A, Madrid-Marina V and Lizano M: The human
papillomavirus (HPV) E1 protein regulates the expression of
cellular genes involved in immune response. Sci Rep. 9:136202019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JE, Chung Y, Rhee S and Kim TH: Untold
story of human cervical cancers: HPV-negative cervical cancer. BMB
Rep. 55:429–438. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang HF, Wang SS, Huang MC, Liang XH, Tang
YJ and Tang YL: Targeting immune-mediated dormancy: A promising
treatment of cancer. Front Oncol. 9:4982019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goss PE and Chambers AF: Does tumour
dormancy offer a therapeutic target? Nat Rev Cancer. 10:871–877.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou YH, Liao SJ, Li D, Luo J, Wei JJ, Yan
B, Sun R, Shu Y, Wang Q, Zhang GM and Feng ZH: TLR4
ligand/H2O2 enhances TGF-β1 signaling to
induce metastatic potential of non-invasive breast cancer cells by
activating non-Smad pathways. PLoS One. 8:e659062013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Liu Q, Dai X, Yan Y, Yang Y, Li H,
Zhou X, Gao W, Li X and Xi Z: Transdifferentiation of type II
alveolar epithelial cells induces reactivation of dormant tumor
cells by enhancing TGF-β1/SNAI2 signaling. Oncol Rep. 39:1874–1882.
2018.PubMed/NCBI
|
|
9
|
Zhou W, Gross KM and Kuperwasser C:
Molecular regulation of Snai2 in development and disease. J Cell
Sci. 132:jcs2351272019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Coll-Bonfill N, Peinado VI, Pisano MV,
Párrizas M, Blanco I, Evers M, Engelmann JC, Garcı́a-Lucio J,
Tura-Ceide O, Meister G, et al: Slug is increased in vascular
remodeling and induces a smooth muscle cell proliferative
phenotype. PLoS One. 11:e01594602016.11 View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Feng Q, Zhang Y, Zheng P and Cui N:
Absence of EpCAM in cervical cancer cells is involved in
sluginduced epithelialmesenchymal transition. Cancer Cell Int.
21:1632021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calcinotto A, Kohli J, Zagato E,
Pellegrini L, Demaria M and Alimonti A: Cellular senescence: Aging,
cancer, and injury. Physiol Rev. 99:1047–1078. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leontieva OV, Lenzo F, Demidenko ZN and
Blagosklonny MV: Hyper-mitogenic drive coexists with mitotic
incompetence in senescent cells. Cell Cycle. 11:4642–4649. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martuscello RT, Vedam-Mai V, McCarthy DJ,
Schmoll ME, Jundi MA, Louviere CD, Griffith BG, Skinner CL, Suslov
O, Deleyrolle LP and Reynolds BA: A supplemented high-fat
low-carbohydrate diet for the treatment of glioblastoma. Clin
Cancer Res. 22:2482–2495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shih JY and Yang PC: The EMT regulator
SNAI2 and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Casimiro MC, Velasco-Velázquez M,
Aguirre-Alvarado C and Pestell RG: Overview of cyclins D1 function
in cancer and the CDK inhibitor landscape: Past and present. Expert
Opin Investig Drugs. 23:295–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allgayer H: Translational research on
u-PAR. Eur J Cancer. 46:1241–1251. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aguirre-Ghiso JA, Estrada Y, Liu D and
Ossowski L: ERKMAPK activity as a determinant of tumor growth and
dormancy; regulation by p38SAPK. Cancer Res. 63:1684–1695.
2003.PubMed/NCBI
|
|
21
|
Tamamouna V, Pavlou E, Neophytou CM,
Papageorgis P and Costeas P: Regulation of metastatic tumor
dormancy and emerging opportunities for therapeutic intervention.
Int J Mol. 23:139312022. View Article : Google Scholar
|
|
22
|
Gomis RR and Gawrzak S: Tumor cell
dormancy. Mol Oncol. 11:62–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang YP, Wang MZ, Luo YR, Shen Y and Wei
ZX: Lentivirus-mediated shRNA interference targeting SLUG inhibits
lung cancer growth and metastasis. Asian Pac J Cancer Prev.
13:4947–4951. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui N, Yang WT and Zheng PS: Slug inhibits
the proliferation and tumor formation of human cervical cancer
cells by up-regulating the p21/p27 proteins and down regulating the
activity of the Wnt/β-catenin signaling pathway via the
trans-suppression Akt1/p-Akt1 expression. Oncotarget.
7:26152–26167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin Y, Chen L, Li L, Huang G, Huang H and
Tang C: SNAI2 promotes the develop- ment of ovarian cancer through
regulating ferroptosis. Bioengineered. 13:6451–6463. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu TY, Chen J, Shang CL, Shen HW, Huang
JM, Liang YC, Wang W, Zhao YH, Liu D, Shu M, et al: Tripartite
motif containing 62 is a novel prognostic marker and suppresses
tumor metastasis via c-Jun/Slug signaling-mediated
epithelial-mesenchymal transition in cervical cancer. J Exp Clin
Cancer Res. 35:1702016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Allgayer H and Aguirre-Ghiso JA: The
urokinase receptor (u-PAR)-a link between tumor cell dormancy and
minimal residual disease in bone marrow? APMIS. 116:602–614. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Wang S, Qian W, Ji D, Wang Q,
Zhang Z, Wang S, Ji B, Fu Z and Sun Y: uc.338 targets p21 and
cyclin D1 via PI3K/AKT pathway activation to promote cell
proliferation in colorectal cancer. Oncol Rep. 40:1119–1128.
2018.PubMed/NCBI
|
|
29
|
Fu T, Liang A and Liu Y: [Role of P21 in
resistance of lung cancer]. Zhongguo Fei Ai Za Zhi. 23:597–602.
2020.(In Chinese). PubMed/NCBI
|
|
30
|
Aguirre-Ghiso JA, Liu D, Mignatti A,
Kovalski K and Ossowski L: Urokinase receptor and fibronectin
regulate the ERKMAPK to p38MAPK activity ratios that determine
carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell.
12:863–879. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Horák P, Kreisingerová K, Réda J,
Ondrušová L, Balko J, Vachtenheim J Jr, Žáková P and Vachtenheim J:
The hedgehog/GLI signaling pathway activates transcription of slug
(Snail2) in melanoma cells. Oncol Rep. 49:752023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gartel AL and Tyner AL: The role of the
cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer
Ther. 1:639–649. 2002.PubMed/NCBI
|
|
33
|
Kim HJ, Hong I, Roh S, Kim S, Kim H, Oh S,
Ahn TS, Kang DH, Baek MJ and Jeong D: High expression of LY6E is an
independent prognostic factor of colorectal cancer patients. Oncol
Rep. 49:802023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu R, Zhao Y, Su S, Kwabil A, Njoku PC,
Yu H and Li X: Unveiling cancer dormancy: Intrinsic mechanisms and
extrinsic forces. Cancer Lett. 591:2168992024. View Article : Google Scholar : PubMed/NCBI
|
